Not applicableStudy completedNCT01985009
What this trial is testing
Prospective, Cross-sectional and Multicenter Study, Evaluating the Diagnosis Accuracy of the Controlled Attenuation Parameter(CAP) Measured by FibroScan® (Either With M+ or XL+ Probe) in Patient With Non-Alcoholic Fatty Liver Disease Using Liver Biopsy as Reference.
Who this might be right for
Non-alcoholic Fatty Liver Disease
Echosens 450